CDYL2 and breast neoplasm: Analyses of multiple publicly available databases, including ONCOMINE 38, Expression Profiling Interactive Analysis (GEPIA) 39, and The Cancer Genome Atlas (TCGA) 40, revealed that the mRNA levels of CDYL2 were significantly higher in breast tumor tissues than those in normal breast tissues (Figure S2-4).